Melco Announces Unaudited First Quarter 2017 Earnings and Declares Quarterly Dividend
May 04, 2017 12:16 pm UTC| Business
MACAU, May 04, 2017 -- Melco Resorts Entertainment Limited (Nasdaq:MLCO), a developer, owner and operator of casino gaming and entertainment casino resort facilities in Asia, today reported its unaudited financial...
FactSet Announces New Executive Vice President, Global Head of Sales and Client Solutions
May 04, 2017 12:10 pm UTC| Business
NORWALK, Conn., May 04, 2017 -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications and industry-leading services, announced today that John W. Wiseman was...
Evine a Sponsor of the 24th Annual Race to Erase MS Gala
May 04, 2017 12:04 pm UTC| Business
The video commerce company participates in the annual star-studded event MINNEAPOLIS, May 04, 2017 -- Evine Live Inc. (“Evine”) (NASDAQ:EVLV), a multiplatform video commerce company (evine.com), today announced that...
ADVA Optical Networking Demonstrates Industry-First 32G Fibre Channel Transmission Over 100km
May 04, 2017 12:03 pm UTC| Business
Field Trial Uses Brocade Gen 6 Fibre Channel Technology and ADVA FSP 3000 CloudConnect(TM) Broomfield, Colorado, USA. May 4, 2017. ADVA Optical Networking today announced that it has successfully transmitted 32Gbit/s...
ADVA Optical Networking Demonstrates Industry-First 32G Fibre Channel Transmission Over 100km
May 04, 2017 12:03 pm UTC| Business
Field Trial Uses Brocade Gen 6 Fibre Channel Technology and ADVA FSP 3000 CloudConnect(TM) Broomfield, Colorado, USA. May 4, 2017. ADVA Optical Networking today announced that it has successfully transmitted 32Gbit/s...
May 04, 2017 12:03 pm UTC| Business
Zug, Switzerland, May 4, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that it...
May 04, 2017 12:03 pm UTC| Business
Zug, Switzerland, May 4, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that it...